Literature DB >> 18357892

[Effect of berberine hydrochloride on the expression of interleukin-1beta and tumor necrosis factor-alpha in periodontal tissues in rats].

Zhan-hai Yu1, Guo-ying Zhang, Xiao-heng Zhang, Jian-dong Du, Qian Yang, Fu-de He.   

Abstract

OBJECTIVE: To determine the effects of berberine hydrochloride on the expressions of interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) in periodontal tissues in rat periodontitis model.
METHODS: Based on the successful rat periodontitis model, the experimental rats were randomized into different groups followed by oral treatment with berberine hydrochloride for 1, 2, 3, 4 weeks and then the rats were sacrificed and analyzed. Pathological assay and HE staining were used to detect the general conditions and pathological changes of rat periodontal tissues. And immunohistochemical staining was conducted to determine the expressions of IL-1beta and TNF-alpha in rats periodontitis model periodontal tissues.
RESULTS: The levels of IL-1beta and TNF-alpha in the periodontitis tissues were significantly higher than that in the control group. Treatment with berberine hydrochloride decreased the levels of IL-1beta and TNF-alpha in periodontitis tissues (P<0.05). Moreover, the general conditions and pathological changes in the control group and groups treated with berberine hydrochloride were much better than that in periodontitis groups.
CONCLUSION: Berberine hydrochloride inhibited the expression of IL-1beta and TNF-alpha in periodontal tissues in rats periodontitis model and promoted the regeneration of the periodontal tissues. This study suggested that berberine hydrochloride may have potential clinical application.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18357892

Source DB:  PubMed          Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi        ISSN: 1000-1182


  1 in total

Review 1.  Berberine as a promising natural compound for the treatment of periodontal disease: A focus on anti-inflammatory properties.

Authors:  Saeed Mohammadian Haftcheshmeh; Amir Abbas Momtazi-Borojeni
Journal:  J Cell Mol Med       Date:  2021-10-30       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.